Logo Logo Logo Logo Logo
  • About GENESIS
  • Team
    • Our Team
    • Scientific Advisory Board
    • Business Advisory Board
  • Services
  • Success stories
  • Methodology
  • Clients
  • GENESIS Tech Transfer Boost
  • Newsroom
  • Careers
  • Contact
  • About GENESIS
  • Team
    • Our Team
    • Scientific Advisory Board
    • Business Advisory Board
  • Services
  • Success stories
  • Methodology
  • Clients
  • GENESIS Tech Transfer Boost
  • Newsroom
  • Careers
  • Contact
  • EN
  • ES
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages

...

21 March, 2023
GENESIS Biomed continues growing and adding value in biomedical sector
GENESIS Biomed continues growing and adding value in biomedical sector

...

15 December, 2022
GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento

...

21 June, 2022
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research

...

26 April, 2022
The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed
The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed

...

06 April, 2022
The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine
The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine

...

14 March, 2022
I3PT founds ANAIS Medical to bring professionals closer to highly realistic medical simulation for interventional procedures
I3PT founds ANAIS Medical to bring professionals closer to highly realistic medical simulation for interventional procedures

...

17 January, 2022
GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation.
GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation.

...

25 November, 2021
Opening of the mowoot crowdfunding campaign with the participation of eit health: Interview with Markus Wilhelms, Daniel Oliver, Patrick Pfeffer and Natalia de la Figuera.
Opening of the Mowoot Crowdfunding campaign with the participation of EIT Health

...

10 November, 2021
Corify Care raises €2.35M to translate its cardiac mapping technology to the market
Corify Care raises €2.35M to translate its cardiac mapping technology to the market

...

06 July, 2021
Show more
Loading...
GENESIS Biomed
Location
Baldiri Reixac 4-8, Parc Científic
08028 Barcelona
Velázquez 25, 2º A
28001 Madrid
Contact
(+34) 93 · 403 · 58 · 53
contact@genesis-biomed.com
Newsletter
Subscribe to our newsletter

Recent Posts
  • What do they say about us?
  • Patient Engagement Platforms in chronic patient monitoring
Last tweeted
GENESIS Biomed
@Genesis_Biomed

📣¡Esta vez los clientes de @Genesis_Biomed hablan por nosotros! No te pierdas el #reportaje “¿Que dicen de nosotros… t.co/4hWCWdDgEy

  • Reply
  • Retweet 0
  • Like 0

©GENESIS Biomed 2018. All rights reserved

Web design by: 021 Informàtics